One multiplex control for 29 cystic fibrosis mutations

Genetic Testing

Volumn 11, Issue 3, 2007, Pages 256-268

  Lebo, Roger V ^a,b   Bixler, Michelle ^a   Galehouse, Donna ^a,b  

^a AKRON CHILDREN'S HOSPITAL   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PLASMID VECTOR;

ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA TEMPLATE; ENZYME SPECIFICITY; GENE AMPLIFICATION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; HUMAN; MOLECULAR CLONING; MUTAGENICITY; POLYMERASE CHAIN REACTION; YEAST;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; GENETIC SCREENING; HUMANS; MODELS, GENETIC; MUTATION;

EID: 35348950054     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2007.9994     Document Type: Article

References (12)

1. Attay S, Galehouse D, Lebo R, Wolf I Hadd A, Wigdall S, Roeven R, Neuwald P (2005) Performance evaluation of multiple synthetic CF mutation controls using multiple ASRs. American College of Medical Genetics Meeting, Abstract, 2005.
2. Chen B, Connell CD, Boone DJ, Amos JA, Beck JC, Chan MM, Farkas DH, Lebo RV, Richards CS, Roa BB, Silverman LM, Barton DE, Bejjani BA, Belloni D, Bernacki B, Brown NM, Aviles-Caffana M, Charache P, Dequeker E, Ferreira-Gonzalez A, Friedman KJ, Greene CL, Grody WW, Highsmith WE, Hinkel C, Lubin IM, Lyon E, Noll WW, Payne D, Pratt VM, Reid Y, Rundell C, Schneider E, Terry P, Willey A, Willey J, Williams LO, Win Deen E, Wolff DJ (2005) Developing a sustainable process to provide quality control materials for genetic testing. Genet Med 7:534-549.
3. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ (2001) Subcommittee on Cystic Fibrosis Screening, Accreditation of Genetic Services Committee, ACMG. American College of Medical Genetics. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 3:149-154.
4. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
5. Lebo RV, Milunsky A, Wang Z, Yamin M (2000) Synthesized multiple control sequences optimize quality control. U.S. Patent application No. 60.503233. U.S. Patent and Trademark Office, Alexandria, VA.
6. Lebo RV, Dunphy G, Quicci M, Galehouse D, Lebo RV (2003) Synthesized multiple control DNA sequences optimize genomic test quality control. In Developing QC materials for genetic testing. Centers for Disease Control and Dept. Health and Human Services, pp. 6-1-6-5.
7. Lebo RV, Dunphy G, Quicci M, Galehouse D (2004) Multiple synthesized and cloned controls optimize clinical test quality. Centers for Disease Control, ACMG Satellite Meeting, Orland, FL.
8. Lebo RV, Grody WW (2007a) Testing and reporting ACMC Cystic Fibrosis Panel results. Genet Test 11(1):11-31.
9. Lebo RV, Grody WW (2007b) Variable penetrance and expressivity of the splice altering 5T sequence in the cystic fibrosis gene. Genet Test 11(1):32-44.
10. Strickberger MW (1968) Genetics. The Macmillian Company, New York, p. 54.
11. Wang Z, Milunsky J, Yamin M, Maher T, Oates R, Milunsky A (2002) Analysis by mass spectrometry of 100 cystic fibrosis gene mutations in 92 patients with congenital bilateral absence of the vas deferens. Hum Reprod 17:2066-2072.
12. Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger D, Mennuti M, Palomaki GE, Propvich BW, Pratt VM, Rohlfs EM, Strom CM, Richards CS, Witt DR, Grody WW (2004) Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 6(5):387-391.